94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Hong Phuong Nguyen1Anh Quynh Le1Enze Liu2,3Annamaria Cesarano4
Francesco DiMeo4†
Fabiana Perna4†
Reuben Kapur1
Brian A. Walker2,3
Ngoc Tung Tran1*- 1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana School of Medicine, Indianapolis, IN, United States
- 2Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, United States
- 3Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, United States
- 4Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States
A Corrigendum on
Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
by Nguyen HP, Le AQ, Liu E, Cesarano A, DiMeo F, Perna F, Kapur R, Walker BA and Tran NT (2023). Front. Immunol. 14:1239614. doi: 10.3389/fimmu.2023.1239614
In the published article, there was an error in affiliation 1. Instead of “Well Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States”, it should be “Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana School of Medicine, Indianapolis, United States.”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: multiple myeloma, PRMT1, targeted therapy, relapsed/refractory myeloma, xenograft model
Citation: Nguyen HP, Le AQ, Liu E, Cesarano A, DiMeo F, Perna F, Kapur R, Walker BA and Tran NT (2023) Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma. Front. Immunol. 14:1334733. doi: 10.3389/fimmu.2023.1334733
Received: 07 November 2023; Accepted: 10 November 2023;
Published: 15 November 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Nguyen, Le, Liu, Cesarano, DiMeo, Perna, Kapur, Walker and Tran. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ngoc Tung Tran, dHVuZ3RyYW5AaXUuZWR1
†Present address: Francesco DiMeo, Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States
Fabiana Perna, Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States